Ceramide production promoter and expression enhancer for ceramide synthase gene

Sardine seed oil-based promoters and enhancers address the issue of reduced ceramide levels by enhancing CERS2, CERS3, and CERS4 gene expression, improving skin barrier function and moisture retention.

JP2024165046AActive Publication Date: 2024-11-28KYUSHU UNIV +2
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
JP2023080866
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-16
Publication Date
2024-11-28
Estimated Expiration
2043-05-16

AI Technical Summary

Technical Problem

Existing technologies fail to effectively enhance ceramide production and synthase gene expression, leading to reduced skin barrier function and moisture retention due to decreased ceramide levels, particularly with aging.

Method used

A ceramide production promoter and synthase gene expression enhancer using sardine seed oil, extracted via supercritical or subcritical carbon dioxide methods, specifically targeting CERS2, CERS3, and CERS4 genes to increase ceramide synthesis.

Benefits of technology

The promoter and enhancer significantly enhance ceramide production, doubling the expression of targeted genes, thereby improving skin barrier function and moisture retention.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024165046000001_ABST
    Figure 2024165046000001_ABST
Patent Text Reader

Abstract

To provide novel ceramide production promoters and expression enhancers for the ceramide synthase gene.SOLUTION: The present invention provides a ceramide production promoter containing Hippophae rhamnoides L. seed oil as an active ingredient, and an expression enhancer for the ceramide synthase gene containing Hippophae rhamnoides L. seed oil as an active ingredient.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a ceramide production promoter and an agent for enhancing the expression of a ceramide synthase gene. [Background technology]

[0002] Ceramide is the main intercellular lipid component in the skin, and plays a major role in the barrier function. When there is a lack of ceramide, the skin cannot retain moisture and becomes dry, and the barrier function is weakened, making the skin more susceptible to external stimuli, which is thought to cause various skin problems. In recent years, it has also been reported that ceramide is involved in various functions in the body other than the barrier function of the skin.

[0003] A number of enzymes are involved in the biosynthesis and metabolism of ceramide, one of which is ceramide synthase. For example, when the activity of ceramide synthase is reduced due to the influence of aging, the amount of ceramide decreases, the balance of intercellular lipids is disturbed, and the barrier function and moisture retention ability of the skin are reduced, which is said to cause dry skin. By promoting the production of ceramide, it is expected that the barrier function of the skin and the moisture retention ability of the skin can be improved. Patent Document 1 and the like are known as examples of enhancing the expression of this ceramide synthase. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Patent Publication No. 2022-170780 Summary of the Invention [Problem to be solved by the invention]

[0005] An object of the present invention is to provide a novel ceramide production promoter and a novel agent for enhancing the expression of a ceramide synthase gene. [Means for solving the problem]

[0006] The present inventors have conducted extensive research to solve the above problems, and as a result have found that the following invention meets the above object, thereby completing the present invention. <1> A ceramide production promoter containing sea buckthorn seed oil as an active ingredient. <2> The seabuckthorn seed oil is a supercritical carbon dioxide extract and / or a subcritical carbon dioxide extract of seabuckthorn seeds. <1> 2. A ceramide production promoter according to claim 1. <3> An expression enhancer for the ceramide synthase gene, containing sea buckthorn seed oil as an active ingredient. <4> The ceramide synthase gene is one or more selected from the group consisting of CERS2, CERS3 and CERS4. <3> An expression enhancer for the ceramide synthase gene described in . Effect of the Invention

[0007] According to the present invention, a novel ceramide production promoter and an agent for enhancing the expression of a ceramide synthase gene are provided. [Brief description of the drawings]

[0008] [Figure 1] FIG. 1 shows the results of a test to evaluate the expression of a ceramide synthase gene. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] The following is a detailed description of the embodiments of the present invention, but the following description of the constituent elements is one example (representative example) of the embodiment of the present invention, and the present invention is not limited to the following content as long as the gist of the present invention is not changed. Note that in this specification, when the expression "~" is used, it is used as an expression including the numerical value or physical property value before and after it.

[0010] The present invention relates to a ceramide production promoter containing seabuckthorn seed oil as an active ingredient. The present invention also relates to an expression enhancer for a ceramide synthase gene containing seabuckthorn seed oil as an active ingredient. Hereinafter, the ceramide production promoter and the expression enhancer for a ceramide synthase gene of the present invention are collectively referred to as "the agent of the present invention".

[0011] (Sea Buckthorn Seed Oil) Sea buckthorn seed oil is an oil (hydrophobic component) extracted from sea buckthorn seeds. Sea buckthorn (Hippophae rhamnoides L.) is a plant of the Hippophae genus of the Elaeaceae family native to Eurasia. Sea buckthorn seeds can be extracted from the fruit itself or from the residue after processing the fruit. For example, the seeds can be selected from the residue removed when sea buckthorn fruits are pressed or strained to process them into juice such as liquid or puree, and used to extract oil. The seeds selected from the residue can be washed with water and dried as appropriate before being used to extract oil.

[0012] The method for extracting the oil is not particularly limited, and known methods can be used. Seabuckthorn seeds are crushed or pulverized as appropriate, and then extracted using an extraction method such as supercritical carbon dioxide extraction, subcritical carbon dioxide extraction, steam distillation, organic solvent extraction, or compression extraction, and the resulting extract can be used as seabuckthorn seed oil.

[0013] Among them, it is preferable to use supercritical carbon dioxide extraction method or subcritical carbon dioxide extraction method, which can extract at low temperature and extract heat-sensitive components without destroying them, and the sea buckthorn seed oil is preferably a supercritical carbon dioxide extract and / or subcritical carbon dioxide extract of sea buckthorn seeds. Specifically, the sea buckthorn seed oil is preferably obtained by a method having a step of using carbon dioxide in a supercritical state or subcritical state as an extraction solvent, extracting oil from sea buckthorn seeds, and removing carbon dioxide. The extraction conditions may be any temperature and pressure that carbon dioxide is in a supercritical state or subcritical state, for example, a temperature of 20 to 80°C and a pressure of 10 to 60 MPa, a temperature of 30 to 80°C and a pressure of 10 to 50 MPa, a temperature of 31 to 60°C and a pressure of 15 to 40 MPa, or a temperature of 31 to 40°C and a pressure of 20 to 30 MPa.

[0014] (Ceramide synthase gene) The agent of the present invention can promote the synthesis of ceramide. In addition, the agent of the present invention can enhance the expression of the ceramide synthase gene, which is one of the enzymes involved in the biosynthesis of ceramide. Enhancement of gene expression means an increase in the transcription product of the gene (DNA) and / or the protein encoded by the gene. Specifically, the agent of the present invention can induce or promote the transcription from the ceramide synthase gene to mRNA, and induce or promote the translation from mRNA to ceramide synthase.

[0015] Six types of ceramide synthase genes, CERS1 to CERS6, have been reported. Among these, the agent of the present invention is preferably used to enhance the expression of one or more genes selected from the group consisting of CERS2, CERS3, and CERS4. CERS2 is a gene that is expressed in large amounts in many cell tissues such as the kidney, liver, and intestine, CERS3 is a gene that is expressed in keratinocytes, and CERS4 is a gene that is expressed not only in the skin but also in leukocytes, the heart, and the liver. The genes are described by their abbreviations according to the official symbols listed in NCBI (http: / / www.ncbi.nlm.nih.gov / ).

[0016] The agent of the present invention can be used in various forms, such as liquids such as aqueous solutions, emulsions, dispersions, and emulsions; semi-solid forms such as gels, ointments, pastes, and creams; and solid forms. For example, it can be in any form of external preparation, such as lotion, cosmetic liquid, cream, milky lotion, sunscreen, cleanser, pack, cosmetic oil, body rinse, massage agent, scalp agent, hair wash, hair rinse, and lip care cosmetic. In the case of external preparations, the effect can be achieved by using a general amount of each external preparation once to several times a day.

[0017] The agent of the present invention may be composed of only sea buckthorn seed oil, or may contain other components such as base materials and additives known in the technical fields of pharmaceuticals, quasi-drugs, cosmetics, etc., in addition to sea buckthorn seed oil, depending on the form, etc. The content of sea buckthorn seed oil in the agent of the present invention is not particularly limited as long as it is within a range in which the effects of the present invention can be achieved, but is preferably 0.5 v / v% or more, and may be 0.6 v / v% or more, 0.8 v / v% or more, 1 v / v% or more, etc. The upper limit of the content of sea buckthorn seed oil in the agent of the present invention is not particularly limited, and may be 90 v / v% or less, 50 v / v% or less, 10 v / v% or less, 5 v / v% or less, etc., depending on the form, etc. EXAMPLES

[0018] The present invention will be described in more detail below with reference to examples. However, the present invention is not limited to the following examples unless the gist of the present invention is changed.

[0019] 1. Test sample (Sea Buckthorn Seed Oil) Seeds were selected from the residue (including seeds and parts of the skin) after processing sea buckthorn juice using the fruits of H. rhamnoides (produced in Inner Mongolia) and washed with drinking water. The dried material was then crushed and the oil was dissolved and separated by supercritical carbon dioxide extraction (pressure 24-26 MPa, temperature 31.25°C, time 3.5 hours), obtaining a brown, transparent extract. The filling was packaged and sealed under aseptic conditions.

[0020] 2. Test Method (1) Evaluation sample Sea Buckthorn Seed Oil Final concentration: 0.2v / v%, 0.4v / v%, 0.5v / v% ·control Ethanol, final concentration: 0.5 v / v%

[0021] (2) Experimental method ·Cell culture Human epidermal keratinocytes (HaCaT cells) were precultured in a φ10 cm dish using Dulbecco's Modified Eagle Medium (DMEM) (high glucose) (containing 1 v / v% penicillin-streptomycin and 10 v / v% fetal bovine serum (FBS)) until confluent. After that, the cells were washed with phosphate-buffered saline (PBS), resuspended in medium, and then plated at 1.0 × 10 5 The cells were seeded at a concentration of 1000 cells / well and cultured overnight in a CO2 incubator (37°C, 5% CO2).

[0022] Adding sample 24 hours after seeding of HaCaT cells, 1 mL of serum-free DMEM (high glucose) (containing 1 v / v% penicillin-streptomycin) containing the sample was added to each well, and the cells were cultured in a CO2 incubator (37°C, 5% CO2) for 48 hours.

[0023] - Changes in gene expression levels by real-time PCR HaCaT cells were harvested 48 hours after the addition of the samples, and total RNA was extracted using an RNeasy Mini kit (Qiagen). cDNA was synthesized from the extracted total RNA using ReverTra Ace qPCR RT Master Mix with gDNA Remover (TOYOBO). Real-time PCR was performed using the synthesized cDNA as a template with an AriaMX (Agilent) device. THUNDERBIRD SYBR qPCR Mix (TOYOBO) was used for the real-time PCR reaction. For the real-time PCR reaction, a forward primer represented by sequence number 1 (5'-CCGATTACCTGCTGGAGTCAG-3') and a reverse primer represented by sequence number 2 (5'-GGCGAAGACGATGAAGATGTTG-3') were used as primers for the ceramide synthase gene CERS2, and a forward primer represented by sequence number 3 (5'-ACATTCCACAAGGCAACCATTG-3') and a reverse primer represented by sequence number 4 (5'-CTCTTGATTCCGCCGACTCC-3') were used as primers for the ceramide synthase gene CERS3. The reverse primers used were the forward primer represented by SEQ ID NO: 5 (5'-GGAGGCCTGTAAGATGGTCA-3') and the reverse primer represented by SEQ ID NO: 6 (5'-GAGGACCAGTCGGGTGTAGA-3') for the ceramide synthase gene CERS4, and the forward primer represented by SEQ ID NO: 7 (5'-GGGTCAGAAGGACTCCTATG-3') and the reverse primer represented by SEQ ID NO: 8 (5'-GTAACAATGCCATGTTCAAT-3') for the internal standard β-actin. The real-time PCR reaction conditions were 40 cycles of a two-step PCR reaction consisting of initial denaturation at 95°C for 60 seconds, followed by denaturation at 95°C for 15 seconds and annealing / extension at 60°C for 60 seconds.

[0024] 3. Evaluation results Figure 1 shows the results of the ceramide synthase gene expression evaluation test. Figure 1 shows the relative values ​​when the control is taken as 1 (n=3, mean ± SD, ** indicates p<0.01), and shows the evaluation results of CERS2, CERS3, and CERS4 (from left to right) at each concentration of control and sea buckthorn seed oil. As shown in Figure 1, it was confirmed that the addition of 0.5 v / v% sea buckthorn seed oil increased the expression of CERS2, CERS3, and CERS4 by approximately two-fold compared to the control. From these results, it can be expected that sea buckthorn seed oil will activate the ceramide synthase gene and increase ceramide production.

Claims

1. A ceramide production promoter containing sea buckthorn seed oil as an active ingredient.

2. The ceramide production promoter according to claim 1, wherein the seabuckthorn seed oil is a supercritical carbon dioxide extract and / or a subcritical carbon dioxide extract of seabuckthorn seeds.

3. An expression enhancer for the ceramide synthase gene, containing sea buckthorn seed oil as an active ingredient.

4. The agent for enhancing expression of a ceramide synthase gene according to claim 3 , wherein the ceramide synthase gene is one or more selected from the group consisting of CERS2, CERS3 and CERS4.

Citation Information

Patent Citations

  • Compositions and methods for improving skin lipid content

    JP2003508486A

  • PPAR activator

    JP2010106001A

  • Compositions and methods for application to the skin

    JP2013522190A

  • Bladder smooth muscle hypercontraction inhibitor

    JP2016216364A

  • Inhibitors for skin inflammation attributed to atmosphere aerosol particles

    JP2016216366A